Please assess the completion status of the following clinical trial:

Trial Title: Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: None
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Histologically confirmed invasive bladder cancer (T2-4a, N0, M0)~  * Adenocarcinoma~ * Transitional cell carcinoma~ * Squamous cell carcinoma~* Localized muscle invasion by surgery or imaging~PATIENT CHARACTERISTICS:~Age:~* 18 and over~Performance status:~* WHO 0-2~Life expectancy:~* Not specified~Hematopoietic:~* WBC greater than 4,000/mm\^3~* Platelet count greater than 100,000/mm\^3~Hepatic:~* Bilirubin less than 1.5 times upper limit of normal (ULN)~* ALT or AST less than 1.5 times ULN~Renal:~* Glomerular filtration rate greater than 25 mL/min~Other:~* Not pregnant~* Negative pregnancy test~* Fertile patients must use effective contraception~* No inflammatory bowel disease~* No other prior malignancy within the past 2 years except adequately treated basal cell skin cancer or carcinoma in situ of the cervix~* No other prior malignancy or uncontrolled systemic disease that would preclude study participation~PRIOR CONCURRENT THERAPY:~Biologic therapy:~* Not specified~Chemotherapy:~* Not specified~Endocrine therapy:~* Not specified~Radiotherapy:~* No prior radiotherapy to the pelvis~Surgery:~* See Disease Characteristics~* No bilateral hip replacements~Other:~* No concurrent metronidazole during fluorouracil administration

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).